RUFY4 deletion prevents pathological bone loss by blocking endo-lysosomal trafficking of osteoclasts

Abstract

Mature osteoclasts degrade bone matrix by exocytosis of active proteases from secretory lysosomes through a ruffled border. However, the molecular mechanisms underlying lysosomal trafficking and secretion in osteoclasts remain largely unknown. Here, we show with GeneChip analysis that RUN and FYVE domain-containing protein 4 (RUFY4) is strongly upregulated during osteoclastogenesis. Mice lacking Rufy4 exhibited a high trabecular bone mass phenotype with abnormalities in osteoclast function in vivo. Furthermore, deleting Rufy4 did not affect osteoclast differentiation, but inhibited bone-resorbing activity due to disruption in the acidic maturation of secondary lysosomes, their trafficking to the membrane, and their secretion of cathepsin K into the extracellular space. Mechanistically, RUFY4 promotes late endosome-lysosome fusion by acting as an adaptor protein between Rab7 on late endosomes and LAMP2 on primary lysosomes. Consequently, Rufy4-deficient mice were highly protected from lipopolysaccharide- and ovariectomy-induced bone loss. Thus, RUFY4 plays as a new regulator in osteoclast activity by mediating endo-lysosomal trafficking and have a potential to be specific target for therapies against bone-loss diseases such as osteoporosis.

References

[1] Zaidi M. Skeletal remodeling in health and disease. Nat. Med., 2007, 13: 791-801

[2] Delaisse JM et al. Re-thinking the bone remodeling cycle mechanism and the origin of bone loss. Bone, 2020, 141

[3] Park JH, Lee NK, Lee SY. Current understanding of RANK signaling in osteoclast differentiation and maturation. Mol. Cells, 2017, 40: 706-713

[4] Baron R et al. Polarized secretion of lysosomal enzymes: co-distribution of cation-independent mannose-6-phosphate receptors and lysosomal enzymes along the osteoclast exocytic pathway. J. Cell Biol., 1988, 106: 1863-1872

[5] Vaananen HK, Zhao H, Mulari M, Halleen JM. The cell biology of osteoclast function. J. Cell Sci., 2000, 113: 377-381

[6] Feng X, Teitelbaum SL. Osteoclasts: new insights. Bone Res., 2013, 1: 11-26

[7] Mellman I. Endocytosis and molecular sorting. Annu. Rev. Cell Dev. Biol., 1996, 12: 575-625

[8] Andrews NW. Regulated secretion of conventional lysosomes. Trends Cell Biol., 2000, 10: 316-321

[9] Dell’Angelica EC, Mullins C, Caplan S, Bonifacino JS. Lysosome-related organelles. FASEB J., 2000, 14: 1265-1278

[10] Obino D et al. Vamp-7-dependent secretion at the immune synapse regulates antigen extraction and presentation in B-lymphocytes. Mol. Biol. Cell, 2017, 28: 890-897

[11] Jung J, Jo HW, Kwon H, Jeong NY. ATP release through lysosomal exocytosis from peripheral nerves: the effect of lysosomal exocytosis on peripheral nerve degeneration and regeneration after nerve injury. Biomed. Res. Int., 2014, 2014

[12] Zhao HB et al. Synaptotagmin VII regulates bone remodeling by modulating osteoclast and osteoblast secretion. Develop. Cell, 2008, 14: 914-925

[13] Luzio JP, Pryor PR, Bright NA. Lysosomes: fusion and function. Nat. Rev. Mol. Cell Biol., 2007, 8: 622-632

[14] Saftig P, Klumperman J. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat. Rev. Mol. Cell Biol., 2009, 10: 623-635

[15] Huotari J, Helenius A. Endosome maturation. Embo J., 2011, 30: 3481-3500

[16] Saffi GT, Botelho RJ. Lysosome fission: planning for an exit. Trends Cell Biol., 2019, 29: 635-646

[17] van der Beek J, Jonker C, van der Welle R, Liv N, Klumperman J. CORVET, CHEVI and HOPS - multisubunit tethers of the endo-lysosomal system in health and disease. J. Cell Sci., 2019, 132

[18] Spang A. Membrane tethering complexes in the endosomal system. Front. Cell Dev. Biol., 2016, 4: 35

[19] Baker RW et al. A direct role for the Sec1/Munc18-family protein Vps33 as a template for SNARE assembly. Science, 2015, 349: 1111-1114

[20] Terawaki S, Camosseto V, Pierre P, Gatti E. RUFY4: immunity piggybacking on autophagy? Autophagy, 2016, 12: 598-600

[21] Char R, Pierre P. The RUFYs, a family of effector proteins involved in intracellular trafficking and cytoskeleton dynamics. Front. Cell Develop. Biol., 2020, 8: 779

[22] Terawaki S et al. RUN and FYVE domain-containing protein 4 enhances autophagy and lysosome tethering in response to Interleukin-4. J. Cell Biol., 2015, 210: 1133-1152

[23] Keren-Kaplan T et al. RUFY3 and RUFY4 are ARL8 effectors that promote coupling of endolysosomes to dynein-dynactin. Nat. Commun., 2022, 13

[24] Zhao HB, Laitala-Leinonen T, Parikka V, Vaananen HK. Downregulation of small GTPase Rab7 impairs osteoclast polarization and bone resorption. J. Biol. Chem., 2001, 276: 39295-39302

[25] Takayanagi H et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell, 2002, 3: 889-901

[26] Boyce BF, Xiu Y, Li J, Xing L, Yao Z. NF-kappaB-mediated regulation of osteoclastogenesis. Endocrinol. Metab. (Seoul), 2015, 30: 35-44

[27] Xie H et al. PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat. Med., 2014, 20: 1270-1278

[28] Martin TJ, Sims NA. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol. Med., 2005, 11: 76-81

[29] Batsir S, Geiger B, Kam Z. Dynamics of the sealing zone in cultured osteoclasts. Cytoskeleton, 2017, 74: 72-81

[30] Destaing O, Saltel F, Geminard JC, Jurdic P, Bard F. Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein. Mol. Biol. Cell, 2003, 14: 407-416

[31] Wang TL, Ming Z, Wu XC, Hong WJ. Rab7: role of its protein interaction cascades in endo-lysosomal traffic. Cell. Signal., 2011, 23: 516-521

[32] Poteryaev D, Datta S, Ackema K, Zerial M, Spang A. Identification of the switch in early-to-late endosome transition. Cell, 2010, 141: 497-508

[33] Eskelinen EL. Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol. Aspects Med., 2006, 27: 495-502

[34] Sardiello M et al. A gene network regulating lysosomal biogenesis and function. Science, 2009, 325: 473-477

[35] Song TT et al. The important role of TFEB in autophagy-lysosomal pathway and autophagy-related diseases: a systematic review. Eur. Rev. Med. Pharmacol. Sci., 2021, 25: 1641-1649

[36] Ng PY, Brigitte Patricia Ribet A, Pavlos NJ. Membrane trafficking in osteoclasts and implications for osteoporosis. Biochem. Soc. Trans., 2019, 47: 639-650

[37] Hayakawa A, Hayes S, Leonard D, Lambright D, Corvera S. Evolutionarily conserved structural and functional roles of the FYVE domain. Biochem. Soc. Symp., 2007, 74: 95-105

[38] Pankiv S et al. FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtubule plus end-directed vesicle transport. J. Cell Biol., 2010, 188: 253-269

[39] Turk B, Turk D, Turk V. Lysosomal cysteine proteases: more than scavengers. Bba-Protein Struct. M., 2000, 1477: 98-111

[40] Costa AG, Cusano NE, Silva BC, Cremers S, Bilezikian JP. Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis. Nat. Rev. Rheumatol., 2011, 7: 447-456

[41] Battaglino RA, Jha P, Sultana F, Liu W, Morse LR. FKBP12: a partner of Snx10 required for vesicular trafficking in osteoclasts. J. Cell Biochem., 2019, 120: 13321-13329

[42] Sultana F et al. Snx10 and PIKfyve are required for lysosome formation in osteoclasts. J. Cell Biochem., 2020, 121: 2927-2937

[43] Li M et al. Gasdermin D maintains bone mass by rewiring the endo-lysosomal pathway of osteoclastic bone resorption. Dev. Cell, 2022, 57: 2365-2380.e2368

[44] Char R et al. RUFY3 regulates endolysosomes perinuclear positioning, antigen presentation and migration in activated phagocytes. Nat. Commun., 2023, 14

[45] Yamamoto H et al. Functional cross-talk between Rab14 and Rab4 through a dual effector, RUFY1/Rabip4. Mol. Biol. Cell, 2010, 21: 2746-2755

[46] Fouraux MA et al. Rabip4’ is an effector of rab5 and rab4 and regulates transport through early endosomes. Mol. Biol. Cell, 2004, 15: 611-624

[47] Cormont M, Mari M, Galmiche A, Hofman P, Le Marchand-Brustel Y. A FYVE-finger-containing protein, Rabip4, is a Rab4 effector involved in early endosomal traffic. Proc. Natl. Acad. Sci. USA, 2001, 98: 1637-1642

[48] Fukuda M, Itoh T. Direct link between Atg protein and small GTPase Rab: Atg16L functions as a potential Rab33 effector in mammals. Autophagy, 2008, 4: 824-826

[49] Fukuda M, Kobayashi H, Ishibashi K, Ohbayashi N. Genome-wide investigation of the Rab binding activity of RUN domains: development of a novel tool that specifically traps GTP-Rab35. Cell Struct. Funct., 2011, 36: 155-170

[50] Coppola V et al. The autophagic protein FYCO1 controls TNFRSF10/TRAIL receptor induced apoptosis and is inactivated by CASP8 (caspase 8). Autophagy, 2023, 19: 2733-2751

[51] Zhao H, Ettala O, Vaananen HK. Intracellular membrane trafficking pathways in bone-resorbing osteoclasts revealed by cloning and subcellular localization studies of small GTP-binding rab proteins. Biochem. Biophys. Res. Commun., 2002, 293: 1060-1065

[52] Roy M, Roux S. Rab GTPases in osteoclastic bone resorption and autophagy. Int. J. Mol. Sci., 2020, 21: 7655

[53] Taylor A et al. Impaired prenylation of Rab GTPases in the gunmetal mouse causes defects in bone cell function. Small GTPases, 2011, 2: 131-142

[54] DeSelm CJ et al. Autophagy proteins regulate the secretory component of osteoclastic bone resorption. Dev. Cell, 2011, 21: 966-974

[55] Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science, 2000, 289: 1508-1514

[56] Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet, 2019, 393: 364-376

[57] Tu KN et al. Osteoporosis: a review of treatment options. P T, 2018, 43: 92-104

[58] Khosla S, Hopbauer LC. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endo, 2017, 5: 898-907

[59] Matsuo K, Irie N. Osteoclast-osteoblast communication. Arch. Biochem. Biophys., 2008, 473: 201-209

[60] Cao X. Targeting osteoclast-osteoblast communication. Nat. Med., 2011, 17: 1344-1346

[61] Maraka S, Kennel KA. Bisphosphonates for the prevention and treatment of osteoporosis. Bmj-Brit Med. J., 2015, 351: h3783

[62] Pawson T, Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science, 1997, 278: 2075-2080

[63] Khor EC et al. Loss of protein kinase C-delta protects against LPS-induced osteolysis owing to an intrinsic defect in osteoclastic bone resorption. PLoS One, 2013, 8: e70815

[64] Li S et al. Conditional knockout of PKC-delta in osteoclasts favors bone mass accrual in males due to decreased osteoclast function. Front. Cell Dev. Biol., 2020, 8: 450

[65] Ye S et al. LIS1 regulates osteoclast formation and function through its interactions with dynein/dynactin and Plekhm1. PLoS One, 2011, 6: e27285

[66] Ng PY et al. Disruption of the dynein-dynactin complex unveils motor-specific functions in osteoclast formation and bone resorption. J. Bone Miner. Res., 2013, 28: 119-134

[67] Fujiwara T et al. PLEKHM1/DEF8/RAB7 complex regulates lysosome positioning and bone homeostasis. JCI Insight, 2016, 1

[68] Suda T, Jimi E, Nakamura I, Takahashi N. Role of 1 alpha,25-dihydroxyvitamin D3 in osteoclast differentiation and function. Methods Enzymol., 1997, 282: 223-235

[69] Zhu H et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat. Protoc., 2010, 5: 550-560

[70] Son HS et al. Benzydamine inhibits osteoclast differentiation and bone resorption via down-regulation of interleukin-1 beta expression. Acta Pharm. Sin. B, 2020, 10: 462-474

[71] Yoon K et al. TRAF6 deficiency promotes TNF-induced cell death through inactivation of GSK3 beta. Cell Death Differ., 2008, 15: 730-738

[72] Kim M et al. Tetraspanin 7 regulates osteoclast function through association with the RANK/αvβ3 integrin complex. J. Cell Physiol., 2022, 237: 846-855

Funding

National Research Foundation of Korea (NRF)(RS-2023-00217798)